P2X7 is reported to be present on some primary human AML cells [46,47], but it remains unknown if the use of P2X7 antagonism in patients with blood cancers to prevent GVHD would increase cancer relapse. The gene discussed is P2RX7; the disease is acute myeloid leukemia.